CAZZANIGA GIOVANNI

Role
Associate professor  
Academic disciplines
Genetica medica (MED/03)

Publications

  • Crespiatico, I., Zaghi, M., Mastini, C., D'Aliberti, D., Mauri, M., Mercado, C., et al. (2024). First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis. BLOOD [10.1182/blood.2023021349]. Detail

  • Elli, E., Mauri, M., D’Aliberti, D., Crespiatico, I., Fontana, D., Redaelli, S., et al. (2024). Idiopathic erythrocytosis: a germline disease?. CLINICAL AND EXPERIMENTAL MEDICINE, 24(1) [10.1007/s10238-023-01283-y]. Detail

  • Saettini, F., Guerra, F., Fazio, G., Bugarin, C., Mcmillan, H., Ohtake, A., et al. (2023). Correction to: Antibody Deficiency in Patients with Biallelic KARS1 Mutations (Journal of Clinical Immunology, (2023), 43, 8, (2115-2125), 10.1007/s10875-023-01584-7) [Altro] [10.1007/s10875-023-01600-w]. Detail

  • Saettini, F., Guerra, F., Fazio, G., Bugarin, C., Mcmillan, H., Ohtake, A., et al. (2023). Antibody Deficiency in Patients with Biallelic KARS1 Mutations. JOURNAL OF CLINICAL IMMUNOLOGY, 43(8), 2115-2125 [10.1007/s10875-023-01584-7]. Detail

  • Bomken, S., Enshaei, A., Schwalbe, E., Mikulasova, A., Dai, Y., Zaka, M., et al. (2023). Molecular characterisation and clinical outcome of B-cell precursor acute lymphoblastic leukaemia with IG-MYC rearrangement. HAEMATOLOGICA, 108(3 (March, 2023)), 717-731 [10.3324/haematol.2021.280557]. Detail

Research projects

PNRR per la Missione 4, componente 2 Investimento 1.1- Avviso 104/2022 | Precision drug targeting of high risk relapsing childhood acute lymphoblastic leukemia
Year: 2022
Call: Bando PRIN 2022
Grantors: MINISTERO DELL'UNIVERSITA' E DELLA RICERCA (MUR)